Donate

PRNewswire

Home»Posts tagged with»PRNewswire

Abbott’s HUMIRA® Approved in Europe for Severe Crohns disease

Abbott's HUMIRA® (Adalimumab) Approved in Europe for Severe Active …Stockhouse27, 2012 /PRNewswire/ — Abbott (NYSE: ABT) announced today that the European Commission has approved HUMIRA® (adalimumab) for the treatment of pediatric patients age…

No Guts Know Glory

IDEAS Kids

IDEAS Kids

IBD Adventures